ClinicalTrials.gg
RecruitingNCT07363538Updated Jan 23, 2026

Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

An interventional study of Surgical operation is performed on neonates aged >7 days (postnatal age) and Surgical operation is performed on neonates aged < 7 days (postnatal age). in Complex Congenital Heart Disease, sponsored by Central China Fuwai Hospital of Zhengzhou University. Recruiting at 12 sites in China. Open to participants aged Up to 7 Days. Per ClinicalTrials.gov, last updated 2026-01-23.

Sponsored by Central China Fuwai Hospital of Zhengzhou University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
738
Allocation
Randomized
Ages
Up to 7 Days
Sex
All
01

Study summary

There remains controversy regarding the optimal timing of surgical treatment for neonatal CCHD (Complex Congenital Heart Disease). Based on the established national multi-center database for surgical treatment of congenital heart disease and the prenatal-postnatal integrated diagnosis and treatment model, this study will conduct a multi-center RCT (Randomized Controlled Trial) to explore the optimal surgical timing for neonatal CCHD. It will also develop innovative comprehensive treatment strategies for critically ill neonatal CCHD patients, use RCT data to evaluate treatment efficacy and establish an evaluation system. This system will be gradually promoted nationwide, aiming to reduce the incidence of perioperative mortality and non-recovery discharge in CCHD patients by 50% (National in-hospital mortality rate of neonatal congenital heart disease surgery in 2023: 6.5%; non-recovery discharge rate: 12.66%), thereby improving the overall level of CCHD treatment in China.

02

Conditions studied

  • Complex Congenital Heart Disease
03

In context

Lead sponsor

Central China Fuwai Hospital of Zhengzhou University is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 7 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Neonates diagnosed with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS via pre-admission cardiac echocardiography;
  2. Patients and families demonstrating high compliance, willing to sign forms and agree to complete one year of follow-up and related examinations.

Exclusion criteria

Exclusion Criteria:

  1. Preterm infant (gestational age \< 36 weeks at birth);
  2. Low birth weight (weight \< 2.5 kg);
  3. Concurrent severe extracardiac anomalies or complex cardiac malformations;
  4. Preoperative respiratory or circulatory instability requiring emergency surgery.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
738 participants (estimated)

Study arms

  • Other
    Control Group

    Surgical operation is performed on neonates aged \>7 days (postnatal age)

    Procedure: Surgical operation is performed on neonates aged >7 days (postnatal age)

  • Experimental
    Experimental Group

    Surgical operation is performed on neonates aged \< 7 days (postnatal age)

    Procedure: Surgical operation is performed on neonates aged < 7 days (postnatal age).

Interventions

  • ProcedureSurgical operation is performed on neonates aged >7 days (postnatal age)

    Surgical operation is performed on neonates aged \>7 days (postnatal age)

  • ProcedureSurgical operation is performed on neonates aged < 7 days (postnatal age).

    Surgical operation is performed on neonates aged \< 7 days (postnatal age).

06

What researchers measure

Primary outcomes

  1. Perioperative Mortality and Non-Rehabilitation Discharge Rate

    Time frame: From enrollment to 1 year after surgery

07

Study locations

2 of 12 sites recruiting
  • Fuwai Hospital, Chinese Academy of Medical Sciences
    Beijing, Beijing Municipality 100037, China
    Recruiting
  • Children's Hospital of Chongqing Medical University
    Chongqing, Chongqing Municipality, China
    Not yet recruiting
  • Guangzhou Women and Children's Medical Center, Guangzhou Medical University
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Central China Fuwai Hospital of Zhengzhou University
    Zhengzhou, Henan 450000, China
    Recruiting
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei, China
    Not yet recruiting
  • The Second Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Not yet recruiting
  • Children's Hospital Affiliated to Nanjing Medical University
    Nanjing, Jiangsu 210008, China
    Not yet recruiting
  • Qingdao Women and Children's Hospital
    Qingdao, Shandong 266000, China
    Not yet recruiting
  • Shanghai Children's Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Not yet recruiting
  • The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
    Xi’an, Shanxi, China
    Not yet recruiting
  • West China Second Hospital of Sichuan University
    Chengdu, Sichuan, China
    Not yet recruiting
  • Children's Hospital Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Not yet recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2025 (actual). Primary completion is estimated for Jan 2029, 37 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2026
First posted
Jan 23, 2026
StartActual
Dec 1, 2025
Primary completionEst.
Jan 31, 2029
CompletionEst.
Jan 31, 2029
Last update
Jan 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07363538
Lead sponsor
Central China Fuwai Hospital of Zhengzhou University
Responsible party
Qihang Yang (postgraduate student, Central China Fuwai Hospital of Zhengzhou University) — Principal investigator
First posted
Jan 23, 2026
Start date
Dec 1, 2025
Primary completion
Jan 31, 2029 (estimated)
Completion
Jan 31, 2029 (estimated)
Last update
Jan 23, 2026

Study contacts

Song Shubo Shubo Song
Contact
songshubo2008@126.com
13523535453

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Central China Fuwai Hospital of Zhengzhou University

Start the discussion